FOLR1

FOLR1 詳細

英語名Folate receptor alpha市販薬剤の数3
治験薬の数27ターゲットの別称FRalpha,KB cells FBP,Adult folate-binding protein,Folate receptor 1,Folate receptor alpha,FR-alpha,FOLR1,Ovarian Tumor-Associated Antigen MOv18,Folate Receptor 1 (Adult),Folate Receptor, Adult,FOLR,FBP,Folate Binding Protein,FRα
研究&開発段階Approved
英語名Folate receptor alpha
ターゲットの別称FRalpha,KB cells FBP,Adult folate-binding protein,Folate receptor 1,Folate receptor alpha,FR-alpha,FOLR1,Ovarian Tumor-Associated Antigen MOv18,Folate Receptor 1 (Adult),Folate Receptor, Adult,FOLR,FBP,Folate Binding Protein,FRα
市販薬剤の数3
治験薬の数27
研究&開発段階Approved

FOLR1 製品リスト

  • 属性

    Protein (22)Cell (1)Antibody (1)

  • 製品ライブラリ

    オンライン (24)

  • Mouse (6)Cynomolgus / Rhesus macaque (4)Human (13)Rabbit (1)

  • タグ

    His Tag (10)His Tag & Avi Tag (6)Fc Tag (4)Fc Tag & Avi Tag (2)- (2)

  • マーカー

    Unconjugated (11)Biotin-labeled (8)FITC Labeled (1)PE Labeled (2)APC Labeled (1)- (1)

FOLR1バックグランド

Folate Receptor 1 (FOLR1) is also known as Folate receptor alpha, Folate Binding Protein (FBP), FOLR, and is a member of the folate receptor (FOLR) family. Members of this gene family have a high affinity for folic acid and for several reduced folic acid derivatives, and mediate delivery of 5-methyltetrahydrofolate to the interior of cells. Mature FOLR1 is an N-glycosylated protein that is anchored to the cell surface by a GPI linkage. FOLR1 is predominantly expressed on epithelial cells and is dramatically upregulated on many carcinomas. FOLR1 is internalized to the endosomal system where it dissociates from its ligand before recycling to the cell surface. A soluble form of FOLR1 can be proteolytically shed from the cell surface into the serum and breast milk. Defects in FOLR1 are the cause of neurodegeneration due to cerebral folate transport deficiency (NCFTD). NCFTD is an autosomal recessive disorder resulting from brain-specific folate deficiency early in life.

FOLR1分子の別称

FOLR-1,FBP,FOLR,FRα

抗体購入プラットフォーム

プロジェクトステージタイプ由来疾患領域適応症
FRα BsAb - 01PCCBispecificHumanized Mouse,NanobodySolid TumorOvarian cancer,Non-small cell lung cancer

ライセンシング

プロジェクト薬物タイプ治療分野適応症ステージエリア
FRα BsAb-ADCBispecific antibodyOncology/CancerOvarian cancerPreclinicalGlobal

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Ricorfotide vedotinCBP-1008Phase 3 ClinicalCoherent Biopharma Suzhou Co LtdBreast Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours
詳細
ArfolitixorinISO-901; 6R-MTHFPhase 3 ClinicalIsofol Medical AbColonic Neoplasms; Colorectal Neoplasms; Osteosarcoma; Rectal Neoplasms
詳細
Rinatabart SesutecanGEN1184; GEN-1184; PRO-1184Phase 3 ClinicalProfoundBio (Suzhou) Co LtdBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Fallopian Tube Neoplasms; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Uterine Neoplasms
詳細
Sofetabart MipitecanLY4170156; LY-4170156Phase 3 ClinicalEli Lilly And Company, Loxo Oncology IncCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms
詳細
Torvutatug SamrotecanAZD5335; AZD-5335Phase 3 ClinicalAstrazeneca PlcAdenocarcinoma of Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Diseases; Solid tumours
詳細
BAT-8006BAT8006; BAT-8006Phase 3 ClinicalBio-Thera Solutions LtdCarcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours
詳細
Luveltamab tazevibulinSTRO-002Phase 2 ClinicalSutro Biopharma IncCarcinoma, Endometrioid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours
詳細
EB-NK-FM (FRalpha/MUC16)EB-NK-FMPhase 2 ClinicalBeijing BiotechCarcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Peritoneal Neoplasms
詳細
EB-NK-MF (MSLN/FRalpha)EB-NK-MFPhase 2 ClinicalBeijing BiotechCarcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Glioblastoma; Glioma; Peritoneal Neoplasms
詳細
18F-AzaFolAzaFol; 18F-AzaFol; [18F]-AzaFolPhase 2 ClinicalInsel Gruppe AG, University Hospital BernGiant Cell Arteritis; Lung Neoplasms; Neoplasms; Ovarian Neoplasms
詳細
Farletuzumab ecteribulinMORAb-202Phase 2 ClinicalBristol-Myers Squibb Company, Eisai Co Ltd, Morphotek IncCarcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Solid tumours
詳細
4S-CAR-FRa4S-CAR-FRaPhase 2 ClinicalShenzhen Geno-Immune Medical InstituteCarcinoma, Transitional Cell; Urinary Bladder Neoplasms
詳細
CBP-1019CBP-1019Phase 2 ClinicalCoherent Biopharma Suzhou Co LtdBreast Neoplasms; Colorectal Neoplasms; Esophageal Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours; Thoracic Neoplasms; Urogenital Neoplasms
詳細
Noscapine-folate conjugatePhase 1 ClinicalEmory UniversityHematologic Neoplasms; Inflammation
詳細
MOv-18 IgEMOv-18 IgE; MOv18; MOv-18Phase 1 ClinicalCancer Research UK, King'S College LondonNeoplasms; Ovarian Neoplasms
詳細
MOv19-BBz CAR-T cells TherapyPhase 1 ClinicalUniversity Of PennsylvaniaCarcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
詳細
ITIL-306ITIL-306Phase 1 ClinicalInstil Bio IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Genital Neoplasms, Female; Solid tumours
詳細
IMGN-151IMGN-151Phase 1 ClinicalImmunogen IncBreast Neoplasms; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Ovarian Neoplasms; Peritoneal Neoplasms; Uterine Cervical Neoplasms
詳細
GenSci-140GenSci140; GenSci-140Phase 1 ClinicalChangchun GeneScience Pharmaceuticals Co LtdOvarian Neoplasms; Solid tumours
詳細
IBI-3010IBI-3010; IBI3010Phase 1 ClinicalNeoplasm Metastasis; Solid tumours
詳細
SYS-6041SYS6041; SYS-6041Phase 1 ClinicalJushi Biopharmaceutical Co LtdNeoplasms; Solid tumours
詳細
FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy(Fred Hutchinson Cancer Center)Phase 1 ClinicalFred Hutchinson Cancer Research CenterLeukemia, Myeloid, Acute; Osteosarcoma
詳細
[177Lu]Lu-EVS459GIZ943; GIZ-943; [177Lu]Lu-EVS459; EVS-459Phase 1 ClinicalNovartis Pharma AgCarcinoma, Non-Small-Cell Lung; Lung Neoplasms; Ovarian Neoplasms
詳細
ZW-191ZW-191Phase 1 ClinicalZymeworks IncCarcinoma, Non-Small-Cell Lung; Genital Neoplasms, Female; Ovarian Neoplasms; Solid tumours
詳細
AMT-151AMT-151Phase 1 ClinicalMultitude Therapeutics IncAdenocarcinoma of Lung; Adenocarcinoma, Clear Cell; Carcinoma, Endometrioid; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Fallopian Tube Neoplasms; Mesothelioma; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
詳細
UB-TT170UB-TT-170; UB_TT170; UB_TT-170; UB-TT170Phase 1 ClinicalUmoja BioPharma IncOsteosarcoma
詳細
CBP-1018CBP-1018Phase 1 ClinicalCoherent Biopharma Suzhou Co LtdCarcinoma, Renal Cell; Lung Neoplasms; Prostatic Neoplasms; Solid tumours
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Pafolacianine SodiumPteroyl-L-Tyr-S0456; OTL-38; EC-17; OTL-0038ApprovedOn Target Laboratories IncCytaluxUnited StatesOvarian NeoplasmsOn Target Laboratories Inc2021-11-29Arthritis, Rheumatoid; Breast Neoplasms; Esophageal Neoplasms; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Inflammatory Bowel Diseases; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Pituitary Neoplasms
詳細
Mirvetuximab soravtansineM9346-Asulfo-SPDB-DM4; IMGN-853; M9346A-sSPDB-DM4; TAK-853; HDM2002; HDM-2002ApprovedImmunogen IncElahere, 爱拉赫United StatesCarcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Fallopian Tube NeoplasmsImmunogen Inc2022-11-14Adenocarcinoma, Clear Cell; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Carcinosarcoma; Cystadenoma, Serous; Endometrial Neoplasms; Fallopian Tube Diseases; Fallopian Tube Neoplasms; Neoplasms; Ovarian Neoplasms; Peritoneal Diseases; Peritoneal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Uterine Neoplasms
詳細
Folinic AcidFTHFApprovedAnemia; Autism Spectrum Disorder; Colorectal Neoplasms; Diarrhea; Down Syndrome; Rectal Neoplasms; Vitamin B 12 Deficiency
詳細

レビュー

  • p***g2025-01-23
    0評価
    As expected, this was a high quality product. I have purchased multiple products from Acro to develop assays in the past. As usual, purity and quantity was confirmed by our in-house quality control group. We are using this in conjunction with #FO1-H82E2 Biotinylated Human FOLR1 Protein, His Avitag. The product was used successfully in an immunization campaign and will also be used for other in-house assays in the future.
  • D***m2022-10-26
    0評価
    We had to order human folate receptor protein for 100 micrograms unit type for one of our sensitive studies. It was crucial that the product work as intended. We received the product in a timely manner, and the product work as intended for one of our studies. As an employee working at a lab, I thank you for all the scientists working hard to make great products!
  • D***n2022-10-26
    0評価
    We had previously ordered this product and we made the mistake of ordering the smaller quantity needed. We contacted customer support letting them know that we needed to switch the order to the larger quantity. They were friendly and helpful when resolving this issue. After the switch, the item in question was sent out very quickly and we were able to continue with our study as soon as it arrived.
詳しく読む
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8